Acceptability and preference of three inhalation devices assessed by the Handling Questionnaire in asthma and COPD patients

Multidisciplinary Respiratory Medicine

Volumn 11, Issue 1, 2016, Pages

  Dal Negro, Roberto W ^a   Povero, Massimiliano ^b  

^a CESFAR   (Italy)

^b AdRes Health Economics and Outcomes Research   (Italy)

Author keywords

Breezhaler; Bronchial Asthma; COPD; Genuair; Handling Questionnaire; Patient preference; Respimat

Indexed keywords

ADULT; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EFFECTIVENESS; DRY POWDER INHALER; EXPERIENCE; FEMALE; HANDLING QUESTIONNAIRE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT PREFERENCE; QUESTIONNAIRE; SOFT MIST INHALER;

EID: 84957604022     PISSN: 1828695X     EISSN: 20496958     Source Type: Journal    
DOI: 10.1186/s40248-016-0044-5     Document Type: Article

References (31)

1. Cross S. Asthma inhalation delivery systems: the patient's viewpoint. J Aersol Med. 2001;14 suppl:S3-7.
2. Magnussen H. Novolizer: how does it fit into inhalation therapy? Curr Med ResOpin. 2005;21 suppl.4:S39-46.
3. Barnes PJ. Introduction: how can we improve asthma management? Curr Res Med Opin. 2005;21 suppl.4:1-3.
4. Melani AS. Inhalatory therapy training: a priority challenge for the physician. Acta Biomed. 2007;78:233-45.
5. Newman SP, Busse WW. Evolution of dry powder inhaler design, formulation, and performance. Respir Med. 2002;96:293-304.
6. Wieshammer S, Dreyhaupt J. Dry powder inhalers: which factors determine the frequency of handling errors? Respiration. 2008;75:18-25.
7. Chapman KR, Fogarty CM, Peckitt C, Lassen C, Jadayel D, Dedericha J, et al. Delivery characteristics and patients' handling of two single-dose dry powder inhalers used in COPD. Int J COPD. 2011;6:353-6.
8. Barrons R, Pegram A, Borrens A. Inhaler device selection: special considerations in elderly patients with chronic obstructive pulmonary disease. Am J Health Syst Pharm. 2011;68:1221-32.
9. Virchow JC. Guidelines versus clinical practice - which therapy and which device. Respir Med. 2004;98(suppl B):S28-34.
10. Virchow JC. What plays a role in the choice of inhaler device for asthma therapy? Curr Med Res Opin. 2005;4(S):19-25.
11. Virchow JC, Crompton GK, Dal Negro RW, Pedersen S, Magnan A, Seidemberg J, et al. Importance of inhaler devices in the management of airway diseases. Respir Med. 2008;102:10-9.
12. Lenney J, Innes JA, Crompton GK. Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. EDICI Respir Med. 2000;94:496-500.
13. Self TH, Arnold LB, Csosnowski LM, Swanson JM, Swanson H. Inadequate skill of healthcare professionals in using asthma inhalation devices. J Asthma. 2007;44:593-8.
14. Dal Negro RW, Guerriero M. Cultural and linguistic testing of the Handling Questionnaire: a specific instrument for assessing the patient's acceptability of dry powder inhalers. Monaldi Arch Chest Dis. 2008;69:170-7.
15. Perpina Tordera M, Viejo JL, Sanchos J, Badia X, Cobos N. Picado C, et al Assessment of patient satisfaction and preferences with inhalers in asthma with the FSI-10 Questionnaire. Arch Broncopneumol. 2008;44:346-52.
16. Hanada S, Wada S, Ohno T, Sawaguchi H, Muraki M, Tohda Y. Questionnaire on switching from the Tiotropium Handihaler to the Respimat inhaler in patients with chronic obstructive pulmonary disease: changes in handling and preferences immediately and several years after the switch. Int J COPD. 2015;10:69-77.
17. Core Team R. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2013. http://www.R-project.org/.
18. Barry PW, O'Callagnan C. The influence of inhaler selection on efficacy of asthma therapies. Adv Drug Deliv Res. 2003;55:879-923.
19. Anderson P. Patient preference for and satisfaction with inhaler devices. Eur Respir Rev. 2005;96:109-16.
20. Schulte M, Osseiran K, Betz R, Wenker M, Brand P, Meyer T, et al. Handling of and preferences for available dry powder inhaler systems by patients with asthma and COPD. J Aerosol Med Pulm Drug Deliv. 2008;21:321-8.
21. van der Palen J, Ginko T, Kroker A, van der Valk P, Goosens M, Padullés L, et al. Preference, satisfaction an errors with two dry powder inhalers in patients with COPD. Expert Opin Drug Deliv. 2013;10:1023-31.
22. Cross R. Asthma inhalation delivery systems: the patient viewpoint. J Aerosol Med. 2001;14 suppl 1:53-7.
23. Chrystin H. Do patients show the same level of adherence with all dry powder inhalers? Intern J Clin Pract Suppl. 2005;149:19-25.
24. van Schayck CP, Bjil-Hofiad ID, Folgering H, Cloosterman SG, Akkermans R, van der Eishout F, et al. Influence of two different inhalation devices on therapy compliance in asthmatic patients. Scand J Prim Health Care. 2002;20:126-8.
25. Anderson P. Use of Respimat soft mist inhaler in COPD patients. Int J Chron Obstruct Pulmon Dis. 2006;1:251-9.
26. Hodder R, Price D. Patient preference for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat Soft Mist Inhaler. Int J Chron Obstruct Pulmon Dis. 2009;4:381-90.
27. Henriet AC, Marchand-Adam S, Mankikian J, Diot P. Respimat, first soft mist inhaler: new perspectives in the management of COPD. Rev Mal Respir. 2010;27:1141-9.
28. Ferguson GT, Ghafouri M, Dai L, Dunn LJ. COPD patient satisfaction with ipratropium bromide/albuterol delivered via Respimat: a randomized controlled study. Int J Chron Obstruct Pulmon Dis. 2013;8:139-50.
29. Lavorini F, Fontana GA. Inhaler technique and patient's preference for dry powder inhaler devices. Expert Opin Drug Deliv. 2014;11:1-3.
30. der Palen JV. Genuair in chronic obstructive pulmonary disease: a novel, user-friendly, multidose, dry powder inhaler. Ther Deliv. 2014;5:795-806.
31. Pascual S, Feimer J, De Soyza A, Sauleda Roig J, Haughney J, Padullès L, et al. Preference, satisfaction and critical errors with Genuair and Breezhaler inhalers in patients with COPD: a randomized, cross-over, multicenter study. NPJ Prim Care Respir Med. 2015;25:15018. doi: 10.1038/npjpcrm.2015.18.